Author

Olga Uspenskaya

Observed names: O V Uspenskaia, O V Uspenskaya, O. Uspenskaya, O. Uspenskaya-Cadoz, O.V. Uspenskaya, Olga Uspenskaia, Olga Uspenskaya-Cadoz, Olga Uspenskaya‐Cadoz, Uspenskaia, Olga, Uspenskaya, Olga, О. В. Успенская

Institution: Centre Hospitalier Universitaire de Rouen

Observed institutions: Centre National de la Recherche Scientifique, Inserm, Eli Lilly (United States), Sechenov University, IQVIA (United Kingdom), LMU Klinikum, Assistance Publique – Hôpitaux de Paris, IQVIA (United States), Pitié-Salpêtrière Hospital, IQVIA (France), Institut du Cerveau, Centre Hospitalier Universitaire de Rouen, Université Pierre-et-Marie-Curie, Ludwig-Maximilians-Universität München

OpenAlex ID: A5043702011

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

2014 · Frank Jessen, Rebecca E. Amariglio, et al. · Alzheimer s & Dementia · 3,006

PDF

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

2018 · Bruno Dubois, Stephane Epelbaum, et al. · The Lancet Neurology · 238

2011 · Leonardo Cruz de Souza, Fabian Corlier, et al. · Brain · 132

Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels

2004 · Olga Uspenskaia, Martin Liebetrau, et al. · BMC Neuroscience · 89

PDF

Validation of Alzheimer’s disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer’s Disease Neuroimaging Initiative (E-ADNI)

2009 · Katharina Buerger, Giovanni Frisoni, et al. · Experimental Gerontology · 63

Blood-Based Microcirculation Markers in Alzheimer's Disease–Diagnostic Value of Midregional Pro-atrial Natriuretic Peptide/C-terminal Endothelin-1 Precursor Fragment Ratio

2009 · Katharina Buerger, Andrea Ernst, et al. · Biological Psychiatry · 39

Prediction of Alzheimer’s Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide

2010 · Katharina Buerger, Olga Uspenskaya, et al. · The Journal of Clinical Psychiatry · 31

Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment

2011 · Philine Schneider, Katharina Buerger, et al. · Biological Psychiatry · 27

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD

2020 · Federica Cacciamani, Luisa Sambati, et al. · Alzheimer s Research & Therapy · 25

PDF

Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia

2012 · Aurélie Kas, Olga Uspenskaya, et al. · Journal of Neurology Neurosurgery & Psychiatry · 25

Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population

2019 · O. Uspenskaya-Cadoz, C. Alamuri, et al. · The Journal of Prevention of Alzheimer s Disease · 22

CTAD taskforce: genetic therapies in Alzheimer’s disease

2025 · D. Jakabek, A.M. Isaacs, et al. · The Journal of Prevention of Alzheimer s Disease · 6

[Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia].

2010 · O V Uspenskaia, N N Iakhno, et al. · PubMed · 6

Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions

2020 · Raymond A. Huml, Olga Uspenskaya-Cadoz, et al. · Therapeutic Innovation & Regulatory Science · 3

Les marqueurs de la maladie d’Alzheimer prodromale

2012 · L.C. de Souza, M. Sarazin, et al. · Revue Neurologique · 3

PO22-TH-04 Memantine hampers the progression of cognitive dysfunction and conversion to dementia in amnestic MCI patients

2009 · O.V. Uspenskaya, N.N. Yakhno · Journal of the Neurological Sciences · 3

Changing concepts and new definitions for Alzheimer’s disease

2016 · Bruno Dubois, Olga Uspenskaya-Cadoz · Oxford University Press eBooks · 2

Vascular Dementia

2010 · Maria Alekseyevna Cherdak, O V Uspenskaya · Neurology neuropsychiatry Psychosomatics · 2

PDF

Impact of the New Conceptual Framework of Alzheimer’s Disease in Imaging Studies

2020 · Bruno Dubois, Nicolas Villain, et al. · Springer eBooks · 1

Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions

2019 · Raymond A. Huml, Olga Uspenskaya-Cadoz, et al. · Therapeutic Innovation & Regulatory Science · 1

TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging

2026 · Michael Benatar, Sami Barmada, et al. · JAMA Neurology

Estimating the prevalence of amyloid positivity among older adults without dementia in the general population

2026 · Lisa Le Scouarnec, Vincent Bouteloup, et al. · npj Dementia

PDF

Methodological approaches to account for assay changes in longitudinal biomarker analysis: insights from Alzheimer’s blood biomarkers in the MEMENTO cohort

2026 · Vincent Bouteloup, Cécile Proust-Lima, et al. · Alzheimer s Research & Therapy

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial)

2020 · Olga Uspenskaya‐Cadoz, Jamie Benoit, et al. · Alzheimer s & Dementia

PDF

Impact of the IWG/Dubois Criteria for Alzheimer’s Disease in Imaging Studies

2014 · Bruno Dubois, Olga Uspenskaya · Springer eBooks

Works count: 37

Citation count: 3,727

H-index: 11

I10-index: 11